Hoxworth Blood Center, Cincinnati Reds partner to strike out blood shortages
March 29, 2024
Hoxworth Blood Center and the Cincinnati Reds are partnering to Strike Out Blood Shortages.
March 29, 2024
Hoxworth Blood Center and the Cincinnati Reds are partnering to Strike Out Blood Shortages.
March 29, 2024
Ohio Governor Mike DeWine appoints Kerry Byrne as University of Cincinnati Board of Trustee member effective March 4, 2024 through January 2033.
March 28, 2024
While navigating the intricacies of pioneering research initiatives, faculty and student innovators can stay current on legal safeguards and protect invention commercialization through the University of Cincinnati’s tech transfer team in the 1819 Innovation Hub.
March 28, 2024
Two Cincinnati Law faculty members were recognized for their scholarly body of work.
March 28, 2024
Two UC Law professors were honored with university-wide awards.
You’ve probably heard all about AI and ChatGPT. “The future” is now, and professionals across many industries use these tools to work more efficiently. For social media managers, connecting with your audience will always require a human touch. Especially for smaller teams, AI can help spark initial ideas, plan content, and save time within your existing workflows.
March 28, 2024
At the University of Cincinnati's 1819 Innovation Hub, the doors to creativity are open wider through the cutting-edge podcast recording studio, now available to all UC affiliates at zero cost.
March 27, 2024
Spectrum News features the story of UC alumna Marian Spencer as part of its storytelling for Women's History Month. Spencer was instrumental in desegregating Cincinnati's Coney Island as well as Cincinnati Public Schools.
March 26, 2024
Ohio Voices, a video segment produced by Spectrum News, paid a visit to the University of Cincinnati to lift the voices of students, staff and faculty. Nine Bearcats were featured in the recent segment.
March 26, 2024
A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas, the most deadly form of brain tumors.